• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov3
ThreeSuns Health Grants Pfizer PD-1/VEGF Dual Antibody License and Registers Phase III Clinical Trials
09:39
Oct23
Sunshine Guojian Pharmaceutical released FY2025 Q3 earnings on October 23 After-Market (BJT), actual revenue CNY 473.98 M, actual EPS CNY 0.3249
01:00
Sunshine Guojian Pharmaceutical released FY2025 9 Months Earnings on October 23 After-Market BJT, actual revenue CNY 1.116 B, actual EPS CNY 0.6353
01:00
Oct16
Sunshine Guojian Pharmaceutical FY2025 Q3 Earnings Release on October 24, 2025 After-Market (BJT)
00:20
Aug29
Sunshine Guojian Pharmaceutical released FY2025 Q2 earnings on August 29 After-Market (BJT), actual revenue CNY 330.89 M, actual EPS CNY 0.1404
01:00
Sunshine Guojian Pharmaceutical released FY2025 Semi-Annual Earnings on August 29 After-Market (BJT), actual revenue CNY 642.01 M, actual EPS CNY 0.31
01:00

Schedules & Filings

Schedules
Filings
Oct23
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 473.98 M, Net Income 208.54 M, EPS 0.3249

Aug30
Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug29
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 330.89 M, Net Income 87.37 M, EPS 0.1404

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy